Successful Trial for New Alzheimer's Vaccine

In the continuing quest to find treatments and cures for Alzheimer's disease and other dementia-related issues, discoveries and breathroughs are being made every day. Earlier this month, a vaccine trial in Sweden showed great promise.
The vaccine, called CAD106, was studied over the course of three years, and showed very positive results. While a previous vaccine led to the development of white blood cells that attacked healthy brain tissue along with the harmful areas, this new vaccine seems to only target the harmful areas. "The researchers found that 80 percent of the patients involved in the trials developed their own protective antibodies against beta-amyloid without suffering any side-effects over the three years of the study."

You can read more about the vaccine and the trial's results here: Alzheimer's vaccine trial a success